Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2016

Open Access 01-12-2016 | Review

White coat hypertension in pediatrics

Authors: Alexander Jurko Jr, Milan Minarik, Tomas Jurko, Ingrid Tonhajzerova

Published in: Italian Journal of Pediatrics | Issue 1/2016

Login to get access

Abstract

The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring.
Literature
1.
go back to reference Landray MJ, Gyh L. White coat hypertension: a recognized syndrome with uncertain implications. J Hum Hypertens. 1999;13:5–8.PubMedCrossRef Landray MJ, Gyh L. White coat hypertension: a recognized syndrome with uncertain implications. J Hum Hypertens. 1999;13:5–8.PubMedCrossRef
2.
go back to reference Chrysant SG. White coat hypertension and white coat worse hypertension. In: Mohler ER, Townsend RR, editors. Advanced therapy in hypertension and vascular disease. Ontario, Canada: Hamilton; 2006. p. 537–43. Chrysant SG. White coat hypertension and white coat worse hypertension. In: Mohler ER, Townsend RR, editors. Advanced therapy in hypertension and vascular disease. Ontario, Canada: Hamilton; 2006. p. 537–43.
3.
go back to reference Suurorg L. Identification and prevalence of white coat hypertension in adolescents. Pap Anthropol. 2003;12:240–50. Suurorg L. Identification and prevalence of white coat hypertension in adolescents. Pap Anthropol. 2003;12:240–50.
5.
go back to reference Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens. 1995;8:790–8.PubMedCrossRef Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens. 1995;8:790–8.PubMedCrossRef
6.
go back to reference Durdik P, Zach R, Jurko A. The importance of ambulatory blood pressure monitoring in the diagnosis of white coat hypertension in children. Acta Medica Martiniana. 2003;3:35–9. Durdik P, Zach R, Jurko A. The importance of ambulatory blood pressure monitoring in the diagnosis of white coat hypertension in children. Acta Medica Martiniana. 2003;3:35–9.
7.
go back to reference Matsuoka S. White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol. 2002;1:950–3.CrossRef Matsuoka S. White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol. 2002;1:950–3.CrossRef
8.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114:555–76.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114:555–76.CrossRef
9.
go back to reference Flynn JT, Ingelfinger JR, Portman RJ. Pediatric Hypertension. New York: Springer; 2013.CrossRef Flynn JT, Ingelfinger JR, Portman RJ. Pediatric Hypertension. New York: Springer; 2013.CrossRef
10.
go back to reference Jurko Jr A, Jurko A, Durdik P, Ruah K. Ambulatory blood pressure monitoring: importance for determination of white coat hypertension in children. Cardiol Young. 2013;23(Suppl):S90. Jurko Jr A, Jurko A, Durdik P, Ruah K. Ambulatory blood pressure monitoring: importance for determination of white coat hypertension in children. Cardiol Young. 2013;23(Suppl):S90.
11.
go back to reference Dolan E, Stanton A, Thijs L, Hinedi K, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study. Hypertension. 2005;46:156–61.PubMedCrossRef Dolan E, Stanton A, Thijs L, Hinedi K, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study. Hypertension. 2005;46:156–61.PubMedCrossRef
12.
go back to reference Jurko Jr A, Ovsonkova A, Hrebik M. Principles of blood pressure measurement and evaluation in childhood. Cardiol. 2009;18:256–62. Jurko Jr A, Ovsonkova A, Hrebik M. Principles of blood pressure measurement and evaluation in childhood. Cardiol. 2009;18:256–62.
13.
go back to reference Sorof JM, Portman RJ. White coat hypertension in children with elevated casual blood pressure. J Pediatr. 2000;137:493–7.PubMedCrossRef Sorof JM, Portman RJ. White coat hypertension in children with elevated casual blood pressure. J Pediatr. 2000;137:493–7.PubMedCrossRef
14.
go back to reference Bald M. Ambulatory blood pressure monitoring for evaluation of hypertension in children. Pediatr Nephrol. 1999;13:996–7.PubMed Bald M. Ambulatory blood pressure monitoring for evaluation of hypertension in children. Pediatr Nephrol. 1999;13:996–7.PubMed
15.
16.
go back to reference Pall D, Kiss I, Katona E. Importance of ambulatory blood pressure monitoring in adolescent hypertension. Kidney Blood Press Res. 2012;35:129–34.PubMedCrossRef Pall D, Kiss I, Katona E. Importance of ambulatory blood pressure monitoring in adolescent hypertension. Kidney Blood Press Res. 2012;35:129–34.PubMedCrossRef
17.
go back to reference Abir-Khalil S, Zaîmi S, Tazi MA, Bendahmane S, Bensaoud O, Benomar M. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring. East Mediterr Health J. 2009;15:400–7.PubMed Abir-Khalil S, Zaîmi S, Tazi MA, Bendahmane S, Bensaoud O, Benomar M. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring. East Mediterr Health J. 2009;15:400–7.PubMed
18.
go back to reference Furusawa EA, Filho UD, Junior DM, Koch VH. Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient. Amer J Hypert. 2011;24:893–7.CrossRef Furusawa EA, Filho UD, Junior DM, Koch VH. Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient. Amer J Hypert. 2011;24:893–7.CrossRef
20.
21.
go back to reference Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurement should be considered? J Hypertens. 2006;24:29–31.PubMedCrossRef Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurement should be considered? J Hypertens. 2006;24:29–31.PubMedCrossRef
22.
go back to reference Pickering T. Should white coat hypertension be treated? J Clin Hypertens. 2005;7:550–3.CrossRef Pickering T. Should white coat hypertension be treated? J Clin Hypertens. 2005;7:550–3.CrossRef
23.
go back to reference Fisher M, Blackwell J, Saseen J. Clinical inquiries. What is the best way to identify patients with white-coat hypertension? J Pharm Pract. 2005;54:549–52. Fisher M, Blackwell J, Saseen J. Clinical inquiries. What is the best way to identify patients with white-coat hypertension? J Pharm Pract. 2005;54:549–52.
24.
go back to reference Sartori M, Semplicini A, Siffert W, et al. G-protein beta3-subunit gene 825 T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension. 2003;42:909–14.PubMedCrossRef Sartori M, Semplicini A, Siffert W, et al. G-protein beta3-subunit gene 825 T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension. 2003;42:909–14.PubMedCrossRef
25.
go back to reference Verma V, Sinah SK. Influence of lean body-mass index versus that of fat mass index on blood pressure of gujarati school going adolescents. Indian J Physiol Phamacol. 2014;58:39–44. Verma V, Sinah SK. Influence of lean body-mass index versus that of fat mass index on blood pressure of gujarati school going adolescents. Indian J Physiol Phamacol. 2014;58:39–44.
26.
go back to reference Ahrens W, Pigeot I, Pohlabeln H, IDEFICS consortium, et al. Prevalence of overweight and obesity in European children below the age of 10. Int J Obes (London). 2014;38(Suppl):S99–107.CrossRef Ahrens W, Pigeot I, Pohlabeln H, IDEFICS consortium, et al. Prevalence of overweight and obesity in European children below the age of 10. Int J Obes (London). 2014;38(Suppl):S99–107.CrossRef
27.
go back to reference Fujita H, Matsouka S, Awayzu M. Ambulatory blood pressure in prehypertensive children and adolescents. Pediatr Nephrol. 2012;27(8):1361–7.PubMedCrossRef Fujita H, Matsouka S, Awayzu M. Ambulatory blood pressure in prehypertensive children and adolescents. Pediatr Nephrol. 2012;27(8):1361–7.PubMedCrossRef
28.
go back to reference Staessen JA, O'Brien ET, Amery AK, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens. 1994;12(Suppl):S1–12.CrossRef Staessen JA, O'Brien ET, Amery AK, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens. 1994;12(Suppl):S1–12.CrossRef
29.
go back to reference Li D, Tao J, Dong Y, et al. Impact of premature birth on long term cardio-cerebral vascular events of puerpera. Zhonghua Xin Xue Guan Bing Za Zhi. 2014;42:598–602.PubMed Li D, Tao J, Dong Y, et al. Impact of premature birth on long term cardio-cerebral vascular events of puerpera. Zhonghua Xin Xue Guan Bing Za Zhi. 2014;42:598–602.PubMed
30.
go back to reference Stabouli S. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20:1151–5.PubMedCrossRef Stabouli S. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20:1151–5.PubMedCrossRef
31.
go back to reference Schusterova I, Jurko A, Minarik M. Left ventricular systolic and diastolic function in children with overweight and obesity. Bratisl Lek Listy. 2013;114:526–30.PubMed Schusterova I, Jurko A, Minarik M. Left ventricular systolic and diastolic function in children with overweight and obesity. Bratisl Lek Listy. 2013;114:526–30.PubMed
32.
go back to reference Verdecchia P, Palatini P, Schillaci G, et al. Independent predictors of isolated clinic (white-coat) hypertension. J Hypertens. 2001;19:1015–20.PubMedCrossRef Verdecchia P, Palatini P, Schillaci G, et al. Independent predictors of isolated clinic (white-coat) hypertension. J Hypertens. 2001;19:1015–20.PubMedCrossRef
33.
go back to reference Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008;153:50–4.PubMedPubMedCentralCrossRef Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008;153:50–4.PubMedPubMedCentralCrossRef
34.
go back to reference Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150:491–7.PubMedCrossRef Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr. 2007;150:491–7.PubMedCrossRef
35.
Metadata
Title
White coat hypertension in pediatrics
Authors
Alexander Jurko Jr
Milan Minarik
Tomas Jurko
Ingrid Tonhajzerova
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2016
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-016-0213-3

Other articles of this Issue 1/2016

Italian Journal of Pediatrics 1/2016 Go to the issue